Fidelity Investments’s Amedisys AMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-17,471
Closed -$1.72M 5372
2025
Q2
$1.72M Buy
17,471
+8,540
+96% +$808K ﹤0.01% 2541
2025
Q1
$827K Buy
8,931
+5,641
+171% +$520K ﹤0.01% 2739
2024
Q4
$299K Buy
3,290
+77
+2% +$7.07K ﹤0.01% 3106
2024
Q3
$310K Sell
3,213
-3,283
-51% -$320K ﹤0.01% 3040
2024
Q2
$596K Buy
6,496
+1,209
+23% +$112K ﹤0.01% 2668
2024
Q1
$487K Buy
5,287
+1,269
+32% +$119K ﹤0.01% 2729
2023
Q4
$382K Buy
4,018
+1,819
+83% +$170K ﹤0.01% 2761
2023
Q3
$205K Buy
2,199
+703
+47% +$65K ﹤0.01% 2881
2023
Q2
$137K Sell
1,496
-214,972
-99% -$17.6M ﹤0.01% 3060
2023
Q1
$15.9M Buy
216,468
+12,495
+6% +$1.08M ﹤0.01% 1707
2022
Q4
$17M Buy
203,973
+178,568
+703% +$16.1M ﹤0.01% 1681
2022
Q3
$2.46M Buy
25,405
+24,318
+2,237% +$2.9M ﹤0.01% 2375
2022
Q2
$114K Sell
1,087
-100,410
-99% -$12.8M ﹤0.01% 3281
2022
Q1
$17.5M Buy
101,497
+93,148
+1,116% +$13.9M ﹤0.01% 1847
2021
Q4
$1.35M Sell
8,349
-24,164
-74% -$3.88M ﹤0.01% 2634
2021
Q3
$4.85M Sell
32,513
-99,766
-75% -$20.7M ﹤0.01% 2379
2021
Q2
$32.4M Sell
132,279
-10,149
-7% -$2.66M ﹤0.01% 1627
2021
Q1
$37.7M Sell
142,428
-23,740
-14% -$6.7M ﹤0.01% 1519
2020
Q4
$48.7M Sell
166,168
-13,773
-8% -$3.53M ﹤0.01% 1335
2020
Q3
$42.5M Sell
179,941
-1,910
-1% -$434K ﹤0.01% 1255
2020
Q2
$36.1M Buy
181,851
+45,232
+33% +$8.44M ﹤0.01% 1296
2020
Q1
$25.1M Sell
136,619
-5,704
-4% -$1.01M ﹤0.01% 1310
2019
Q4
$23.8M Sell
142,323
-86,340
-38% -$12.8M ﹤0.01% 1529
2019
Q3
$30M Sell
228,663
-43,246
-16% -$5.63M ﹤0.01% 1407
2019
Q2
$33M Sell
271,909
-98,880
-27% -$11.7M ﹤0.01% 1411
2019
Q1
$45.7M Buy
370,789
+43,844
+13% +$5.5M 0.01% 1255
2018
Q4
$38.3M Sell
326,945
-94,046
-22% -$11.1M 0.01% 1262
2018
Q3
$52.6M Sell
420,991
-282,004
-40% -$31.1M 0.01% 1251
2018
Q2
$60.1M Sell
702,995
-263,200
-27% -$19.3M 0.01% 1197
2018
Q1
$58.3M Sell
966,195
-32,679
-3% -$1.86M 0.01% 1226
2017
Q4
$52.6M Sell
998,874
-139,865
-12% -$7.37M 0.01% 1268
2017
Q3
$63.7M Sell
1,138,739
-584,214
-34% -$30.9M 0.01% 1191
2017
Q2
$108M Sell
1,722,953
-629,679
-27% -$36.7M 0.01% 948
2017
Q1
$120M Buy
2,352,632
+152,632
+7% +$7.28M 0.02% 911
2016
Q4
$93.8M Sell
2,200,000
-400,000
-15% -$17M 0.01% 1017
2016
Q3
$123M Sell
2,600,000
-585,000
-18% -$29.2M 0.02% 886
2016
Q2
$161M Sell
3,185,000
-2,400
-0.1% -$121K 0.02% 762
2016
Q1
$154M Sell
3,187,400
-307,600
-9% -$11.9M 0.02% 776
2015
Q4
$137M Buy
3,495,000
+462,600
+15% +$18.5M 0.02% 826
2015
Q3
$115M Sell
3,032,400
-561,400
-16% -$23.7M 0.02% 897
2015
Q2
$143M Hold
3,593,800
0.02% 869
2015
Q1
$96.2M Sell
3,593,800
-25,000
-0.7% -$705K 0.01% 1047
2014
Q4
$106M Sell
3,618,800
-120,200
-3% -$2.97M 0.01% 977
2014
Q3
$75.4M Sell
3,739,000
-640,500
-15% -$12.4M 0.01% 1104
2014
Q2
$73.3M Hold
4,379,500
0.01% 1172
2014
Q1
$65.2M Hold
4,379,500
0.01% 1198
2013
Q4
$64.1M Hold
4,379,500
0.01% 1187
2013
Q3
$75.4M Hold
4,379,500
0.01% 1082
2013
Q2
$50.9M Buy
+4,379,500
New +$50.2M 0.01% 1234

Other funds holding AMED

Fidelity Investments's AMED Position: Q3 2025 in Review

Fidelity Investments sold out of Amedisys (AMED) in Q3 2025, closing a stake of 17,471 shares — an estimated $1.72M sold.

Fidelity Investments first reported a position in AMED in Q2 2013 and held it in 49 quarters. The position peaked at $161M in Q2 2016. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • Fidelity Investments reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • Fidelity Investments sold 17,471 Amedisys shares in Q3 2025, an estimated $1.72M.
  • Fidelity Investments first reported a position in Amedisys in Q2 2013 and held it in 49 quarters.
  • Fidelity Investments's Amedisys position peaked at $161M in Q2 2016.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Fidelity Investments's 13F filing for Q3 2025, filed 13 Nov 2025.